| 代码 | 名称 | 最新价 | 涨跌幅 √ | 涨跌额 | 成交额 | | --- | --- | --- | --- | --- | --- | | ZEPP | 华米科技 | 24.060 | 38.12% | +6.640 | 2741.59万 | | MENS | 健永生技 | 28.930 | 23.32% | +5.470 | 277.98万 | | ANTE | AirNet Technology | 2.680 | 22.37% | +0.490 | 87.07万 | | PLUT | 贝德斯金融 | 3.540 | 18.39% | +0.550 | 36.8万 | | IMAB | I-Mab | 3.370 | 15.02% | +0.440 | 1123.17万 | 中概股收盘涨幅前五的个股为：华米科技涨38.12%，健永生技涨23.32%，AirNet Technology涨22.37%， 贝德斯金融涨18.39%，I-Mab涨15.02%。(格隆汇) ...

Core Insights - Zepp Health Corporation (formerly known as Huami Corporation) experienced a significant stock price increase of 20.49% on August 5, reaching $20.99 per share with a trading volume of $5.12 million, resulting in a total market capitalization of $302 million [1] Financial Performance - For the fiscal year ending June 30, 2025, Zepp Health reported total revenue of $97.94 million, reflecting a year-over-year growth of 21.52% [1] - The company recorded a net loss attributable to shareholders of $27.48 million, which represents a decrease of 7.32% compared to the previous year [1] - Basic earnings per share were reported at -$0.11 [1] Company Overview - Zepp Health is a cloud-based health service provider and a leader in smart wearable technology [1] - The company is notable for being the first smart hardware innovation company from China to be listed on the U.S. capital market, having gone public on the New York Stock Exchange (NYSE) in February 2018 under the ticker symbol ZEPP [1] - The company's mission is to "connect technology with health," and it aims to build a global health ecosystem through its "chip-end-cloud" strategy, which encompasses chips, smart wearable devices, and health cloud services [1] - Utilizing advanced artificial intelligence algorithms and big data analytics, Zepp Health offers 24/7 health monitoring services and integrates smart wearable technology into the global Internet of Things to enhance user convenience and lifestyle [1]

Core Insights - Zepp Health Corporation (formerly known as Huami Corporation) reported a total revenue of $97.943 million for the fiscal year ending June 30, 2025, representing a year-over-year growth of 21.52% [1][2] - The company recorded a net loss attributable to shareholders of $27.481 million, which is a decrease of 7.32% compared to the previous year, resulting in a basic earnings per share of -$0.11 [2] Company Overview - Zepp Health Corporation is a cloud-based health service provider and a leader in smart wearable technology, being the first smart hardware innovation company from China to list on the US capital market in February 2018 [2] - The company's mission is "Technology Connects Health," and it aims to build a global health ecosystem through its "chip-end-cloud" strategy, which includes chips, smart wearable devices, and health cloud services [2] - Utilizing advanced artificial intelligence algorithms and big data analytics, the company offers 24/7 health monitoring services and integrates smart wearable technology into the global Internet of Things to create a smarter and more convenient lifestyle for users [2]

Group 1 - Xindong Company (02400) reported a positive earnings forecast, expecting revenue of at least RMB 3.05 billion for the first half of 2025, a year-on-year increase of approximately 37%, and a net profit of at least RMB 790 million, a year-on-year increase of about 215% [1] - Yimai Sunshine (02522) also announced a positive earnings forecast, expecting revenue between RMB 450 million to 480 million for the first half of the year, a year-on-year increase of approximately 8.77% to 16.03%, and a net profit of RMB 14.5 million to 16.5 million, a year-on-year increase of about 1350% to 1550% [1] - Tianli International Holdings (01773) plans to repurchase shares up to a total of HKD 200 million based on market conditions, believing that the share buyback plan is in the best interest of the company and its shareholders [2] Group 2 - Liaogang Co., Ltd. (02880) reported a total operating revenue of RMB 5.693 billion for the first half of 2025, a year-on-year increase of 5.93%, and a net profit attributable to shareholders of RMB 956 million, a year-on-year increase of 110.78% [2] - Yuan Zheng Technology (02488) reported a revenue of RMB 982 million for the first half of 2025, a year-on-year increase of 9.75%, and a net profit of RMB 195 million, a year-on-year increase of 27.74% [2] - Geekplus Technology (02590) expects revenue between RMB 995 million to 1.03 billion for the first half of the year, a year-on-year increase of 27% to 32%, while the net loss is expected to narrow significantly [3] Group 3 - Lee & Man Paper Manufacturing (02314) and other leading companies in the paper industry have initiated a price increase for various products starting August 1, indicating a significant acceleration in price adjustment frequency within the industry [3] - Xinda Biopharmaceutical (01801) announced that its innovative oral small molecule GLP-1R agonist IBI3032 has received IND approval from the FDA [4] - Heyu-B (02256) reported a revenue of RMB 612 million for the first half of the year, a year-on-year increase of 23.1%, and a net profit of RMB 328 million, a year-on-year increase of 58.84% [4] Group 4 - Bilibili (BILI.US) is expected to achieve a revenue growth of 20% year-on-year to RMB 7.3 billion in the second quarter, driven by stable performance in mobile games [5][6] - Li Auto (LI.US) launched the Li Xiang i8, with deliveries starting on August 20, and received positive outlooks from multiple institutions [6] - Xpeng Motors (XPEV.US) achieved a new monthly delivery record in July, delivering 36,717 smart electric vehicles, a year-on-year increase of 229% [7]

Group 1 - Recent global capital markets have shown complex and varied trends, with Chinese assets performing notably well in overseas markets [1] - The Nasdaq Golden Dragon China Index surged over 1.8%, and the three-times leveraged FTSE China ETF saw a peak increase of over 6% [1] - Chinese concept stocks experienced significant gains, with Huami Technology's stock price soaring over 48% following better-than-expected earnings, leading to a year-to-date increase of 570% [1] Group 2 - Foreign capital allocation strategies are shifting, with a notable return of active foreign capital to the Hong Kong stock market for the first time in 41 weeks [3] - Active foreign capital recorded a net inflow of $429,000 into the Hong Kong and ADR markets, ending a 40-week outflow streak [3] - Goldman Sachs raised its 12-month target for the MSCI China Index from 85 to 90 points, maintaining an "overweight" rating on Chinese stocks, indicating increased investor interest [3] Group 3 - Market expectations for a Federal Reserve rate cut in September have risen, with a 94.4% probability of a 25 basis point cut [4] - The overall U.S. stock market has strengthened, with major indices like the Dow, Nasdaq, and S&P 500 all rising over 1%, marking the largest single-day gain since May [4] - Analysts suggest that A-shares and H-shares will benefit from international capital inflows due to supportive policies and improving fundamentals [4]

Group 1 - The top five gaining Chinese concept stocks at the close were Lichen International, ATA Creativity Global, Huami Technology, Puhua Biotechnology, and Feitian Zhaoye, with respective gains of 48.81%, 36.11%, 34%, 24.45%, and 23.46% [1] - Lichen International's latest price was 5.610, with a gain of 1.840 and a trading volume of 14.39 million [1] - ATA Creativity Global's latest price was 1.470, with a gain of 0.390 and a trading volume of 7.29 million [1] Group 2 - Huami Technology's latest price was 17.420, with a gain of 4.420 and a trading volume of 22.89 million [1] - Puhua Biotechnology's latest price was 0.8199, with a gain of 0.1611 and a trading volume of 1.36 million [1] - Feitian Zhaoye's latest price was 1.0000, with a gain of 0.1900 and a trading volume of 16.93 million [1]

财务数据显示，截至2025年03月31日，华米科技收入总额3853.7万美元，同比减少3.55%；归母净利 润-1974.1万美元，同比减少33.67%。 8月4日，华米科技(ZEPP)盘中上涨41.85%，截至22:00，报18.44美元/股，成交1142.73万美元，总市值 2.65亿美元。 8月3日，华米科技将于(美东)盘后披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国 当地时间，实际披露日期以公司公告为准）。 资料显示，Zepp Health Corporation(更名前:华米公司)是一家基于云的健康服务提供商,拥有全球领先的 智能可穿戴技术。华米科技也是中国首家登陆美国资本市场的智能硬件创新公司,于2018年2月在美国纽 约证券交易所(NYSE)上市(股票代码:ZEPP)。 本文源自：金融界 大事提醒： 公司的使命是"科技连接健康",通过"芯端云"的战略,布局芯片、智能可穿戴终端及健康云服务,构筑全球 健康生态,做用户最信赖的伙伴。基于强大的人工智能算法和大数据分析能力,华米科技为用户提供7x24 小时健康监测服务,并通过将智能可穿戴技术集成到全球物联网,为用户创造更智能、便捷的 ...

Core Insights - Huami Technology (ZEPP.US) experienced a rapid stock price increase of over 48%, reaching a high of $19.26, the highest since March 2022, with a cumulative rise of over 550% in the past month [1] Financial Performance - For the second quarter ending June 30, 2025, the company reported a significant revenue growth of 46.2% year-over-year, exceeding previous guidance and marking the first overall revenue growth since 2021 [1] - The core brand Amazfit has been identified as the growth engine, with strong sales from the Bip 6 and Active 2 series, as well as robust performance from the high-end T-Rex 3 model. New products like the Balance 2 smartwatch and Helio wristband launched in June also contributed significantly [1] - The company reported a GAAP net loss of $7.7 million and an adjusted net loss of $6.16 million, representing a year-over-year reduction of 28.6% and 30.2% respectively, with a stable gross margin of 36.2% [1] Future Outlook - Management anticipates third-quarter revenue to reach between $72 million and $76 million, reflecting a year-over-year growth of 70% to 79% [1] - CEO Huang Wang stated that the current quarter marks the beginning of an upward cycle, supported by a rich pipeline of innovations that will sustain growth in the second half of the year and beyond, reinforcing Amazfit's leadership in the performance wearables sector [1]

Core Insights - Huami Technology (ZEPP.US) reported a significant revenue growth of 46.2% year-on-year for the second quarter ending June 30, 2025, marking the first overall revenue increase since 2021 [1] - The core brand Amazfit has become the growth engine, with strong sales from the Bip 6 and Active 2 series, and the high-end T-Rex 3 model performing well [1] - The company has narrowed its GAAP net loss to $7.7 million and adjusted net loss to $6.16 million, a reduction of 28.6% and 30.2% respectively compared to the same period last year, with a stable gross margin of 36.2% [1] Financial Performance - The financial health of the company continues to improve, with operating expenses decreasing quarter-on-quarter and cash reserves reaching $95.3 million at the end of the period [1] - The company strategically increased inventory to address new product launches and tariff risks while advancing a stock buyback plan to demonstrate long-term confidence [1] Strategic Initiatives - The strategic transformation has shown significant results, with Zepp focusing on building the Amazfit brand ecosystem and launching the AI-enabled Zepp OS 5.0 system [1] - Marketing efforts include signing NFL star Derrick Henry and utilizing multi-platform global marketing, resulting in a second-place brand progress ranking in the U.S. market during Amazon Prime membership days, and a 60% year-on-year sales increase in the EMEA region [1] Future Outlook - For the third quarter, management expects revenue to reach between $72 million and $76 million, representing a year-on-year growth of 70% to 79% [2] - The CEO indicated that this quarter marks the beginning of an upward cycle, supported by a rich pipeline of innovations to sustain growth in the second half of the year and beyond, solidifying Amazfit's leadership in the performance wearables sector [2]

Financial Data and Key Metrics Changes - The company achieved a remarkable 46% year-over-year increase in revenue, reaching $59.4 million, marking the first quarter of year-over-year revenue growth since 2021 [6][20] - Gross margin for Q2 2025 was 36.2%, consistent with Q1 2025 but slightly down year-over-year due to a higher proportion of lower-margin entry-level products [21][22] - Adjusted operating loss narrowed to $4.9 million, an improvement of 42% compared to the previous year [26] Business Line Data and Key Metrics Changes - The Amazfit brand contributed all revenue, with strong demand for the Big Six and Active Two series, as well as the T Rex Three series [20] - The Balance Two smartwatch and Helios Stripe were introduced, with the latter receiving acclaim for its heart rate monitoring capabilities [9][10] - Entry-level products like the BIP Six and Active Two continued to see steady growth, supported by retail and Amazon partnerships [10][11] Market Data and Key Metrics Changes - In the U.S., Amazfit ranked as the second most improved wearable brand year-over-year, with significant sales growth in the EMEA region, particularly in Germany, Italy, and France [19][15] - Sales surged by approximately 60% in the EMEA region during Amazon Prime Day compared to the previous year [15] Company Strategy and Development Direction - The company is focused on a multi-layered global marketing strategy leveraging partnerships with athletes and influencers to enhance brand recognition [12][14] - A commitment to expanding the premium product portfolio is evident, with plans for new product launches to capture additional market share [16][28] - The operational strategy includes diversifying manufacturing across China and Vietnam to mitigate tariff impacts and enhance resilience [12][38] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, emphasizing the importance of product competitiveness and brand awareness [6][17] - The outlook for Q3 2025 anticipates revenue in the range of $72 million to $76 million, representing 70% to 79% year-over-year growth [28] - Management noted that the upcoming peak season for the industry will drive continued growth and value creation for stakeholders [17][28] Other Important Information - The company has cumulatively retired $8 million of debt since 2023, enhancing its capital structure [27] - Research and development expenses increased by 4.2% year-over-year to $10.3 million, reflecting investments in new technologies [23] Q&A Session Summary Question: What are the drivers behind the recent spike in share price? - Management noted strong product reception and brand visibility, along with a value discovery journey in the market, leading to a revaluation of the company's stock [31][32] Question: How many more product launches are expected in the second half of the year? - Management indicated that there will be exciting new products in the pipeline for Q3 and Q4, matching or exceeding the previous year's launches [33][34] Question: What gross margin expectations are there for the full year? - Management expects gross margins to improve in the second half of the year, potentially reaching closer to 40% as new products are launched [35][36] Question: What percentage of imports to the U.S. comes from Vietnam, and what are the current tariffs? - Management stated that tariffs on products shipped from China to the U.S. are just below 25%, while those from Vietnam are close to zero due to tariff waivers [38] Question: What sales contribution is expected from the new Helios Stripe launch? - Management highlighted that the Helios Stripe has received positive customer feedback and carries a healthy gross margin, with expectations for strong sales performance [44][45] Question: What are the main drivers for the strong guidance for Q3? - Management cited strong performance from entry-level products, successful new product launches, and seasonal trends as key drivers for anticipated growth in Q3 [53][56]